(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AFFIMER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

AFFIMER

ST13

US500000079154375

Class

1, 5

Filing

79154375

Registration

4975232

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

58

Latest update

07/19/2025

Classification

Registered

Trademark type

Word

Nice classes

1, 5

Filing date

01/07/2014

Registration date

06/14/2016

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/03/2023

Last transaction

07/19/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Wetherby, GB

Examiner

LAW, CHRISTOPHER

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Avacta Limited
Avacta Limited

Representatives

Christina M. Licursi Wolf Greenfield & Sacks, P.C.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents for use in scientific research; reagents for use in scientific screening

Class 5

Reagents for use in veterinary and medical diagnostic testsexcept tests in the field of immunohematology and transfusion medicine; reagents for use in medical and veterinary research except screening in the field of immunohematology and transfusion medicine; diagnostic reagents for use in assays of biological samplesparticularly bloodexcept in the field of immunohematology and transfusion medicine; diagnostic reagents for use in assays of samplesparticularly bloodexcept in the field of immunohematology and transfusion medicine; diagnostic reagents for use in medical and veterinary screeningexcept screening in the field of immunohematology and transfusion medicine; diagnostic preparations for use in relation to food intolerance testing; pharmaceutical substances based on affinity reagents equivalent to antibodies and products comprising themall for use in medical and/or veterinary screeningexcept screening in the field of immunohematology and transfusion medicine; antigens for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; diagnostic and/or pharmaceutical preparations containing antigensexcept preparations in the field of immunohematology and transfusion medicine; substrates impregnated with or carrying antigens for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; affinity reagents equivalent to antibodies for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; pharmaceutical or diagnostic preparations containing affinity reagents equivalent to antibodiesexcept in connection with immunohematology or transfusion medicine; substrates impregnated with or carrying affinity reagents equivalent to antibodies for pharmaceutical purposes other than immunohematology or transfusion medicine ; wound dressings medical plasters; antiseptic wipes; diagnostic agents for medical use except in connection with immunohematology and transfusion medicinecontaining any of the aforesaid products

Publications

History of USPTO decisions and trademark events.

58 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/18/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/01/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/01/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/01/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/01/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/01/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/01/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

06/14/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

04/15/2024

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

03/12/2024

INPC

INVALIDATION PROCESSED

03/12/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/03/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

02/01/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/03/2023

71AG

REGISTERED-SEC.71 ACCEPTED

07/03/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/03/2023

ES71

TEAS SECTION 71 RECEIVED

12/14/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/14/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/07/2019

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

04/11/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/01/2016

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/12/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/21/2016

FIMP

FINAL DISPOSITION PROCESSED

09/21/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/14/2016

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/01/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

06/14/2016

TMBN

TTAB RELEASE CASE TO TRADEMARKS

05/11/2016

OP.T

OPPOSITION TERMINATED NO. 999999

05/11/2016

OP.D

OPPOSITION DISMISSED NO. 999999

05/11/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/06/2016

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/06/2016

RFNP

REFUSAL PROCESSED BY IB

10/09/2015

OP.I

OPPOSITION INSTITUTED NO. 999999

09/24/2015

OPNS

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

09/23/2015

OPNC

OPPOSITION NOTICE (IB REFUSAL) CREATED

09/23/2015

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

06/24/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/26/2015

PUBO

PUBLISHED FOR OPPOSITION

05/26/2015

GPNX

NOTIFICATION PROCESSED BY IB

05/22/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/06/2015

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/06/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/06/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/17/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/15/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/15/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/15/2015

ALIE

ASSIGNED TO LIE

04/14/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/09/2015

RFNT

REFUSAL PROCESSED BY IB

12/05/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/19/2014

RFRR

REFUSAL PROCESSED BY MPU

11/19/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/18/2014

MAFR

APPLICATION FILING RECEIPT MAILED

11/18/2014

CNRT

NON-FINAL ACTION WRITTEN

11/17/2014

DOCK

ASSIGNED TO EXAMINER

11/12/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/12/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/06/2014

Continuous trademark protection

Get notified about every new filing that threatens AFFIMER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.